Thromboprophylaxis and bleeding risk in postoperative for hip and knee arthroplasty: a retrospective study on 1082 patients

被引：0
|
作者：
Roumagnac, A. [1 ]
Wallet, F. [1 ]
Maucort-Boulch, D. [2 ,3 ]
Delsuc, C. [1 ]
Petit, P. -Y. [1 ]
Piriou, V. [1 ]
机构：
[1] Ctr Hosp Lyon Sud, Serv Anesthesie Reanimat, F-69310 Pierre Benite, France
[2] Univ Lyon 1, Equipe Biostat Sante, CNRS UMR 5558, Villeurbanne, France
[3] Hosp Civils Lyon, Serv Biostat, Lyon, France
来源：
ANNALES FRANCAISES D ANESTHESIE ET DE REANIMATION | 2014年 / 33卷
关键词：
D O I：
10.1016/j.annfar.2014.07.309
中图分类号：
R614 [麻醉学];
学科分类号：
100217 ;
摘要：
R286
引用
收藏
页码：A189 / A190
页数：2
相关论文
共 50 条
  • [1] Comparison of Postoperative Bleeding in Total Hip and Knee Arthroplasty Patients Receiving Rivaroxaban, Enoxaparin, or Aspirin for Thromboprophylaxis
    Lindquist, Desirae E.
    Stewart, David W.
    Brewster, Aaryn
    Waldroup, Caitlin
    Odle, Brian L.
    Burchette, Jessica E.
    El-Bazouni, Hadi
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2018, 24 (08) : 1315 - 1321
  • [2] THROMBOPROPHYLAXIS AND THE RISK OF POST-DISCHARGE VENOUS THROMBOEMBOLISM AND BLEEDING IN PATIENTS UNDERGOING TOTAL HIP OR KNEE ARTHROPLASTY
    Huo, M. H.
    Spencer, D. L.
    Fan, Y.
    Borah, B. J.
    Mills, R. M.
    Klaskala, W.
    VALUE IN HEALTH, 2012, 15 (04) : A112 - A112
  • [3] Efficacy and safety of rivaroxaban thromboprophylaxis after arthroplasty of the hip or knee: retrospective cohort study
    Loganathan, V.
    Hua, A.
    Patel, S.
    Gibbons, C.
    Vizcaychipi, M. P.
    ANNALS OF THE ROYAL COLLEGE OF SURGEONS OF ENGLAND, 2016, 98 (07) : 507 - 515
  • [4] Risk factors of postoperative nausea and vomiting after total hip arthroplasty or total knee arthroplasty: a retrospective study
    Wang, Yingjie
    Yang, Qi
    Lin, Jin
    Qian, Wenwei
    Jin, Jin
    Gao, Peng
    Zhang, Baozhong
    Feng, Bin
    Weng, Xisheng
    ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (17)
  • [5] Thromboprophylaxis After Hip or Knee Arthroplasty
    Chan, Noel C.
    Bhandari, Mohit
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2022, 328 (08): : 712 - 713
  • [6] Thromboprophylaxis following hip and knee arthroplasty
    Mirkazemi, C.
    Bereznicki, L. R.
    Peterson, G. M.
    INTERNAL MEDICINE JOURNAL, 2013, 43 (02) : 124 - 129
  • [7] Postoperative Anaemia Is a Risk Factor for Bleeding-Related Event in Thromboprophylaxis Using Fondaparinux Sodium Injection after Total Knee or Hip Arthroplasty
    Enokiya, Tomoyuki
    Hasegawa, Masahiro
    Morikawa, Yoshihiko
    Muraki, Yuichi
    Sudo, Akihiro
    Okuda, Masahiro
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2020, 43 (02) : 266 - 271
  • [8] Thromboprophylaxis after hip and knee arthroplasty: Is aspirin an effective and safe solution? A retrospective comparative study
    Fischbacher, Arnaud
    Fischer, Jean-Francois
    Husmann, Olivier
    Lunebourg, Alexandre
    SWISS MEDICAL WEEKLY, 2018, 148 : 52S - 53S
  • [9] Comparison of Postoperative Bleeding in Total Hip and Knee Arthroplasty Patients Receiving Rivaroxaban or Enoxaparin
    Ricket, Abby L.
    Stewart, David W.
    Wood, Robert C.
    Cornett, Lyndsey
    Odle, Brian
    Cluck, David
    Freshour, Jessica
    El-Bazouni, Hadi
    ANNALS OF PHARMACOTHERAPY, 2016, 50 (04) : 270 - 275
  • [10] Multimodal thromboprophylaxis for total hip and knee arthroplasty based on risk assessment
    Dorr, Lawrence D.
    Gendelman, Vlad
    Maheshwari, Aditya V.
    Boutary, Myriam
    Wan, Zhinian
    Long, William T.
    JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 2007, 89A (12): : 2648 - 2657
12345